Ronawk, innovators in stem cell expansion technologies, has launched a trial program to provide its patented tissue-blocks (T-Blocks) to commercial cell producers and regenerative medicine partners. Their T-Blocks are a 3D matrix consumable product that enable the stem cell industry by providing means to increase stem cell production by 3,600 times vs. traditional expansion methods.
Ronawk is accelerating their T-Block testing program by partnering with commercial cell producers and regenerative medicine technology leaders.
As COVID-19 continues to wage war on the world, researchers in an Olathe-based lab are generating trillions of human cells that could be used to cure the ever-lingering virus.
T-Blocks are changing the way primary stem cells are grown. The technology, owned by the Kansas City-based startup, Ronawk LLC and co-founders A.J. Mellott and Heather Decker, is conducting extensive research on stem cells at the University of Kansas Medical Center.
Ronawk is here to support the drive to rapidly develop effective diagnostic tools, therapies, and vaccines against COVID-19.
Dr. Mellott and Ronawk are accepted into the Class of 2020 Pipeline Fellows.
Ronawk LLC is honored to have won Cellink’s first Shark Tank Competition this year at the Partnership Conference in New Orleans!
Ronawk, LLC was recognized by the KC Biz Journal during their successful Q4 '19 Trade Show bringing large publicity behind their 3D T-Block cell technology.
Ronawk’s first trade show was a great success. Multiple members of the greater Kansas City community stopped by, which included a member of
Ronawk spent the last year going through many development tracks in the Kansas City area for start-ups. In their most recent track...